1) Our company is directly involved in using AI to design clinical trials. We use machine learning and neural networks to predict which patients would be most responsive to a particular therapy, and use this to help clients recruit patients and design stratified clinical trials. Based on our past success, we believe this approach to be more widely used by companies, as it has clear potential in saving time and expense.
2) Yes – we have experience in oncology and discovery of immunomodulators for various diseases. We have very recently discovered a therapeutic candidate for atomic dermatitis, and are pleased that our partner has taken this into the clinic as a proof of concept study.